CD4 and non-small cell lung carcinoma: Similarly, in non-small cell lung cancer (NSCLC), the high expression on CD4+ T cells was correlated with reduced overall survival, high rate of lymphocyte metastasis, and low secretion of cytokines, including IFN-γ, IL-2, IL-4, IL-10, and IL-17 [80].